The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Flurbiprofen Market Research Report 2024
Synopsis
The global Flurbiprofen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Flurbiprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Flurbiprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Flurbiprofen in Nonsteroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Flurbiprofen include Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie and Abbott, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flurbiprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flurbiprofen.
Report Scope
The Flurbiprofen market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flurbiprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flurbiprofen companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Mylan Pharmaceuticals
Tokuhon
Recordati
Mikasa Seiyaku
Bausch Health
Pfizer
AbbVie
Abbott
Allergan
Pharma-Logic
Kaken Pharma
Mitsubishi Tanab
Sun Pharma
Aa Pharma
Pro Doc Limitee
PD-Rx Pharmaceuticals
Beijing Taide Pharmaceutical
Wuhan Daan Pharmaceutical
Segment by Type
Injection
Patch
Tablet
Segment by Application
Nonsteroidal Anti-Inflammatory Drugs
Topical Administration for Joint And Muscle Pain
Soft Tissue Disease
Dysmenorrhea
Post-Operative Pain
Toothache
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flurbiprofen companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Flurbiprofen market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Flurbiprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Flurbiprofen is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Flurbiprofen in Nonsteroidal Anti-Inflammatory Drugs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Flurbiprofen include Teva, Mylan Pharmaceuticals, Tokuhon, Recordati, Mikasa Seiyaku, Bausch Health, Pfizer, AbbVie and Abbott, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Flurbiprofen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flurbiprofen.
Report Scope
The Flurbiprofen market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flurbiprofen market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flurbiprofen companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Mylan Pharmaceuticals
Tokuhon
Recordati
Mikasa Seiyaku
Bausch Health
Pfizer
AbbVie
Abbott
Allergan
Pharma-Logic
Kaken Pharma
Mitsubishi Tanab
Sun Pharma
Aa Pharma
Pro Doc Limitee
PD-Rx Pharmaceuticals
Beijing Taide Pharmaceutical
Wuhan Daan Pharmaceutical
Segment by Type
Injection
Patch
Tablet
Segment by Application
Nonsteroidal Anti-Inflammatory Drugs
Topical Administration for Joint And Muscle Pain
Soft Tissue Disease
Dysmenorrhea
Post-Operative Pain
Toothache
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Flurbiprofen companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Flurbiprofen Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Injection
1.2.3 Patch
1.2.4 Tablet
1.3 Market by Application
1.3.1 Global Flurbiprofen Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Nonsteroidal Anti-Inflammatory Drugs
1.3.3 Topical Administration for Joint And Muscle Pain
1.3.4 Soft Tissue Disease
1.3.5 Dysmenorrhea
1.3.6 Post-Operative Pain
1.3.7 Toothache
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Flurbiprofen Market Perspective (2019-2030)
2.2 Flurbiprofen Growth Trends by Region
2.2.1 Global Flurbiprofen Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Flurbiprofen Historic Market Size by Region (2019-2024)
2.2.3 Flurbiprofen Forecasted Market Size by Region (2025-2030)
2.3 Flurbiprofen Market Dynamics
2.3.1 Flurbiprofen Industry Trends
2.3.2 Flurbiprofen Market Drivers
2.3.3 Flurbiprofen Market Challenges
2.3.4 Flurbiprofen Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Flurbiprofen Players by Revenue
3.1.1 Global Top Flurbiprofen Players by Revenue (2019-2024)
3.1.2 Global Flurbiprofen Revenue Market Share by Players (2019-2024)
3.2 Global Flurbiprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Flurbiprofen Revenue
3.4 Global Flurbiprofen Market Concentration Ratio
3.4.1 Global Flurbiprofen Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Flurbiprofen Revenue in 2023
3.5 Flurbiprofen Key Players Head office and Area Served
3.6 Key Players Flurbiprofen Product Solution and Service
3.7 Date of Enter into Flurbiprofen Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Flurbiprofen Breakdown Data by Type
4.1 Global Flurbiprofen Historic Market Size by Type (2019-2024)
4.2 Global Flurbiprofen Forecasted Market Size by Type (2025-2030)
5 Flurbiprofen Breakdown Data by Application
5.1 Global Flurbiprofen Historic Market Size by Application (2019-2024)
5.2 Global Flurbiprofen Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Flurbiprofen Market Size (2019-2030)
6.2 North America Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Flurbiprofen Market Size by Country (2019-2024)
6.4 North America Flurbiprofen Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Flurbiprofen Market Size (2019-2030)
7.2 Europe Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Flurbiprofen Market Size by Country (2019-2024)
7.4 Europe Flurbiprofen Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Flurbiprofen Market Size (2019-2030)
8.2 Asia-Pacific Flurbiprofen Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Flurbiprofen Market Size by Region (2019-2024)
8.4 Asia-Pacific Flurbiprofen Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Flurbiprofen Market Size (2019-2030)
9.2 Latin America Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Flurbiprofen Market Size by Country (2019-2024)
9.4 Latin America Flurbiprofen Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Flurbiprofen Market Size (2019-2030)
10.2 Middle East & Africa Flurbiprofen Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Flurbiprofen Market Size by Country (2019-2024)
10.4 Middle East & Africa Flurbiprofen Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Flurbiprofen Introduction
11.1.4 Teva Revenue in Flurbiprofen Business (2019-2024)
11.1.5 Teva Recent Development
11.2 Mylan Pharmaceuticals
11.2.1 Mylan Pharmaceuticals Company Detail
11.2.2 Mylan Pharmaceuticals Business Overview
11.2.3 Mylan Pharmaceuticals Flurbiprofen Introduction
11.2.4 Mylan Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024)
11.2.5 Mylan Pharmaceuticals Recent Development
11.3 Tokuhon
11.3.1 Tokuhon Company Detail
11.3.2 Tokuhon Business Overview
11.3.3 Tokuhon Flurbiprofen Introduction
11.3.4 Tokuhon Revenue in Flurbiprofen Business (2019-2024)
11.3.5 Tokuhon Recent Development
11.4 Recordati
11.4.1 Recordati Company Detail
11.4.2 Recordati Business Overview
11.4.3 Recordati Flurbiprofen Introduction
11.4.4 Recordati Revenue in Flurbiprofen Business (2019-2024)
11.4.5 Recordati Recent Development
11.5 Mikasa Seiyaku
11.5.1 Mikasa Seiyaku Company Detail
11.5.2 Mikasa Seiyaku Business Overview
11.5.3 Mikasa Seiyaku Flurbiprofen Introduction
11.5.4 Mikasa Seiyaku Revenue in Flurbiprofen Business (2019-2024)
11.5.5 Mikasa Seiyaku Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Detail
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Flurbiprofen Introduction
11.6.4 Bausch Health Revenue in Flurbiprofen Business (2019-2024)
11.6.5 Bausch Health Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Flurbiprofen Introduction
11.7.4 Pfizer Revenue in Flurbiprofen Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Flurbiprofen Introduction
11.8.4 AbbVie Revenue in Flurbiprofen Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Abbott
11.9.1 Abbott Company Detail
11.9.2 Abbott Business Overview
11.9.3 Abbott Flurbiprofen Introduction
11.9.4 Abbott Revenue in Flurbiprofen Business (2019-2024)
11.9.5 Abbott Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Flurbiprofen Introduction
11.10.4 Allergan Revenue in Flurbiprofen Business (2019-2024)
11.10.5 Allergan Recent Development
11.11 Pharma-Logic
11.11.1 Pharma-Logic Company Detail
11.11.2 Pharma-Logic Business Overview
11.11.3 Pharma-Logic Flurbiprofen Introduction
11.11.4 Pharma-Logic Revenue in Flurbiprofen Business (2019-2024)
11.11.5 Pharma-Logic Recent Development
11.12 Kaken Pharma
11.12.1 Kaken Pharma Company Detail
11.12.2 Kaken Pharma Business Overview
11.12.3 Kaken Pharma Flurbiprofen Introduction
11.12.4 Kaken Pharma Revenue in Flurbiprofen Business (2019-2024)
11.12.5 Kaken Pharma Recent Development
11.13 Mitsubishi Tanab
11.13.1 Mitsubishi Tanab Company Detail
11.13.2 Mitsubishi Tanab Business Overview
11.13.3 Mitsubishi Tanab Flurbiprofen Introduction
11.13.4 Mitsubishi Tanab Revenue in Flurbiprofen Business (2019-2024)
11.13.5 Mitsubishi Tanab Recent Development
11.14 Sun Pharma
11.14.1 Sun Pharma Company Detail
11.14.2 Sun Pharma Business Overview
11.14.3 Sun Pharma Flurbiprofen Introduction
11.14.4 Sun Pharma Revenue in Flurbiprofen Business (2019-2024)
11.14.5 Sun Pharma Recent Development
11.15 Aa Pharma
11.15.1 Aa Pharma Company Detail
11.15.2 Aa Pharma Business Overview
11.15.3 Aa Pharma Flurbiprofen Introduction
11.15.4 Aa Pharma Revenue in Flurbiprofen Business (2019-2024)
11.15.5 Aa Pharma Recent Development
11.16 Pro Doc Limitee
11.16.1 Pro Doc Limitee Company Detail
11.16.2 Pro Doc Limitee Business Overview
11.16.3 Pro Doc Limitee Flurbiprofen Introduction
11.16.4 Pro Doc Limitee Revenue in Flurbiprofen Business (2019-2024)
11.16.5 Pro Doc Limitee Recent Development
11.17 PD-Rx Pharmaceuticals
11.17.1 PD-Rx Pharmaceuticals Company Detail
11.17.2 PD-Rx Pharmaceuticals Business Overview
11.17.3 PD-Rx Pharmaceuticals Flurbiprofen Introduction
11.17.4 PD-Rx Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024)
11.17.5 PD-Rx Pharmaceuticals Recent Development
11.18 Beijing Taide Pharmaceutical
11.18.1 Beijing Taide Pharmaceutical Company Detail
11.18.2 Beijing Taide Pharmaceutical Business Overview
11.18.3 Beijing Taide Pharmaceutical Flurbiprofen Introduction
11.18.4 Beijing Taide Pharmaceutical Revenue in Flurbiprofen Business (2019-2024)
11.18.5 Beijing Taide Pharmaceutical Recent Development
11.19 Wuhan Daan Pharmaceutical
11.19.1 Wuhan Daan Pharmaceutical Company Detail
11.19.2 Wuhan Daan Pharmaceutical Business Overview
11.19.3 Wuhan Daan Pharmaceutical Flurbiprofen Introduction
11.19.4 Wuhan Daan Pharmaceutical Revenue in Flurbiprofen Business (2019-2024)
11.19.5 Wuhan Daan Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Flurbiprofen Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Injection
Table 3. Key Players of Patch
Table 4. Key Players of Tablet
Table 5. Global Flurbiprofen Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Flurbiprofen Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Flurbiprofen Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Flurbiprofen Market Share by Region (2019-2024)
Table 9. Global Flurbiprofen Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Flurbiprofen Market Share by Region (2025-2030)
Table 11. Flurbiprofen Market Trends
Table 12. Flurbiprofen Market Drivers
Table 13. Flurbiprofen Market Challenges
Table 14. Flurbiprofen Market Restraints
Table 15. Global Flurbiprofen Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Flurbiprofen Market Share by Players (2019-2024)
Table 17. Global Top Flurbiprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flurbiprofen as of 2023)
Table 18. Ranking of Global Top Flurbiprofen Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Flurbiprofen Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Flurbiprofen Product Solution and Service
Table 22. Date of Enter into Flurbiprofen Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Flurbiprofen Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Flurbiprofen Revenue Market Share by Type (2019-2024)
Table 26. Global Flurbiprofen Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Flurbiprofen Revenue Market Share by Type (2025-2030)
Table 28. Global Flurbiprofen Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Flurbiprofen Revenue Market Share by Application (2019-2024)
Table 30. Global Flurbiprofen Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Flurbiprofen Revenue Market Share by Application (2025-2030)
Table 32. North America Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Flurbiprofen Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Flurbiprofen Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Flurbiprofen Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Flurbiprofen Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Flurbiprofen Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Flurbiprofen Market Size by Country (2025-2030) & (US$ Million)
Table 47. Teva Company Detail
Table 48. Teva Business Overview
Table 49. Teva Flurbiprofen Product
Table 50. Teva Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 51. Teva Recent Development
Table 52. Mylan Pharmaceuticals Company Detail
Table 53. Mylan Pharmaceuticals Business Overview
Table 54. Mylan Pharmaceuticals Flurbiprofen Product
Table 55. Mylan Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 56. Mylan Pharmaceuticals Recent Development
Table 57. Tokuhon Company Detail
Table 58. Tokuhon Business Overview
Table 59. Tokuhon Flurbiprofen Product
Table 60. Tokuhon Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 61. Tokuhon Recent Development
Table 62. Recordati Company Detail
Table 63. Recordati Business Overview
Table 64. Recordati Flurbiprofen Product
Table 65. Recordati Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 66. Recordati Recent Development
Table 67. Mikasa Seiyaku Company Detail
Table 68. Mikasa Seiyaku Business Overview
Table 69. Mikasa Seiyaku Flurbiprofen Product
Table 70. Mikasa Seiyaku Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 71. Mikasa Seiyaku Recent Development
Table 72. Bausch Health Company Detail
Table 73. Bausch Health Business Overview
Table 74. Bausch Health Flurbiprofen Product
Table 75. Bausch Health Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 76. Bausch Health Recent Development
Table 77. Pfizer Company Detail
Table 78. Pfizer Business Overview
Table 79. Pfizer Flurbiprofen Product
Table 80. Pfizer Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 81. Pfizer Recent Development
Table 82. AbbVie Company Detail
Table 83. AbbVie Business Overview
Table 84. AbbVie Flurbiprofen Product
Table 85. AbbVie Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 86. AbbVie Recent Development
Table 87. Abbott Company Detail
Table 88. Abbott Business Overview
Table 89. Abbott Flurbiprofen Product
Table 90. Abbott Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 91. Abbott Recent Development
Table 92. Allergan Company Detail
Table 93. Allergan Business Overview
Table 94. Allergan Flurbiprofen Product
Table 95. Allergan Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 96. Allergan Recent Development
Table 97. Pharma-Logic Company Detail
Table 98. Pharma-Logic Business Overview
Table 99. Pharma-Logic Flurbiprofen Product
Table 100. Pharma-Logic Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 101. Pharma-Logic Recent Development
Table 102. Kaken Pharma Company Detail
Table 103. Kaken Pharma Business Overview
Table 104. Kaken Pharma Flurbiprofen Product
Table 105. Kaken Pharma Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 106. Kaken Pharma Recent Development
Table 107. Mitsubishi Tanab Company Detail
Table 108. Mitsubishi Tanab Business Overview
Table 109. Mitsubishi Tanab Flurbiprofen Product
Table 110. Mitsubishi Tanab Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 111. Mitsubishi Tanab Recent Development
Table 112. Sun Pharma Company Detail
Table 113. Sun Pharma Business Overview
Table 114. Sun Pharma Flurbiprofen Product
Table 115. Sun Pharma Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 116. Sun Pharma Recent Development
Table 117. Aa Pharma Company Detail
Table 118. Aa Pharma Business Overview
Table 119. Aa Pharma Flurbiprofen Product
Table 120. Aa Pharma Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 121. Aa Pharma Recent Development
Table 122. Pro Doc Limitee Company Detail
Table 123. Pro Doc Limitee Business Overview
Table 124. Pro Doc Limitee Flurbiprofen Product
Table 125. Pro Doc Limitee Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 126. Pro Doc Limitee Recent Development
Table 127. PD-Rx Pharmaceuticals Company Detail
Table 128. PD-Rx Pharmaceuticals Business Overview
Table 129. PD-Rx Pharmaceuticals Flurbiprofen Product
Table 130. PD-Rx Pharmaceuticals Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 131. PD-Rx Pharmaceuticals Recent Development
Table 132. Beijing Taide Pharmaceutical Company Detail
Table 133. Beijing Taide Pharmaceutical Business Overview
Table 134. Beijing Taide Pharmaceutical Flurbiprofen Product
Table 135. Beijing Taide Pharmaceutical Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 136. Beijing Taide Pharmaceutical Recent Development
Table 137. Wuhan Daan Pharmaceutical Company Detail
Table 138. Wuhan Daan Pharmaceutical Business Overview
Table 139. Wuhan Daan Pharmaceutical Flurbiprofen Product
Table 140. Wuhan Daan Pharmaceutical Revenue in Flurbiprofen Business (2019-2024) & (US$ Million)
Table 141. Wuhan Daan Pharmaceutical Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Flurbiprofen Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Flurbiprofen Market Share by Type: 2023 VS 2030
Figure 3. Injection Features
Figure 4. Patch Features
Figure 5. Tablet Features
Figure 6. Global Flurbiprofen Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Flurbiprofen Market Share by Application: 2023 VS 2030
Figure 8. Nonsteroidal Anti-Inflammatory Drugs Case Studies
Figure 9. Topical Administration for Joint And Muscle Pain Case Studies
Figure 10. Soft Tissue Disease Case Studies
Figure 11. Dysmenorrhea Case Studies
Figure 12. Post-Operative Pain Case Studies
Figure 13. Toothache Case Studies
Figure 14. Other Case Studies
Figure 15. Flurbiprofen Report Years Considered
Figure 16. Global Flurbiprofen Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Flurbiprofen Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Flurbiprofen Market Share by Region: 2023 VS 2030
Figure 19. Global Flurbiprofen Market Share by Players in 2023
Figure 20. Global Top Flurbiprofen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flurbiprofen as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Flurbiprofen Revenue in 2023
Figure 22. North America Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Flurbiprofen Market Share by Country (2019-2030)
Figure 24. United States Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Flurbiprofen Market Share by Country (2019-2030)
Figure 28. Germany Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Flurbiprofen Market Share by Region (2019-2030)
Figure 36. China Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Flurbiprofen Market Share by Country (2019-2030)
Figure 44. Mexico Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Flurbiprofen Market Share by Country (2019-2030)
Figure 48. Turkey Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Flurbiprofen Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Teva Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 51. Mylan Pharmaceuticals Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 52. Tokuhon Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 53. Recordati Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 54. Mikasa Seiyaku Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 55. Bausch Health Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 56. Pfizer Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 57. AbbVie Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 58. Abbott Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 59. Allergan Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 60. Pharma-Logic Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 61. Kaken Pharma Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 62. Mitsubishi Tanab Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 63. Sun Pharma Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 64. Aa Pharma Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 65. Pro Doc Limitee Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 66. PD-Rx Pharmaceuticals Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 67. Beijing Taide Pharmaceutical Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 68. Wuhan Daan Pharmaceutical Revenue Growth Rate in Flurbiprofen Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
